U.S. flag

An official website of the United States government

NM_000214.3(JAG1):c.439+1G>A AND Alagille syndrome due to a JAG1 point mutation

Germline classification:
Pathogenic (3 submissions)
Last evaluated:
Aug 29, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001853157.7

Allele description [Variation Report for NM_000214.3(JAG1):c.439+1G>A]

NM_000214.3(JAG1):c.439+1G>A

Gene:
JAG1:jagged canonical Notch ligand 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
20p12.2
Genomic location:
Preferred name:
NM_000214.3(JAG1):c.439+1G>A
HGVS:
  • NC_000020.11:g.10663962C>T
  • NG_007496.1:g.15085G>A
  • NM_000214.3:c.439+1G>AMANE SELECT
  • LRG_1191t1:c.439+1G>A
  • LRG_1191:g.15085G>A
  • NC_000020.10:g.10644610C>T
  • NM_000214.2:c.439+1G>A
Links:
dbSNP: rs863223648
NCBI 1000 Genomes Browser:
rs863223648
Molecular consequence:
  • NM_000214.3:c.439+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Name:
Alagille syndrome due to a JAG1 point mutation
Synonyms:
HEPATIC DUCTULAR HYPOPLASIA, SYNDROMATIC; Alagille Syndrome 1; JAG1-Related Alagille Syndrome
Identifiers:
MONDO: MONDO:0016862; MedGen: C1956125; Orphanet: 52; OMIM: 118450

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002242883Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Aug 29, 2024)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

SCV004847132Genomic Medicine Lab, University of California San Francisco
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Feb 23, 2023)
paternalclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV005068255Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jul 1, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedpaternalyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Splicing in action: assessing disease causing sequence changes.

Baralle D, Baralle M.

J Med Genet. 2005 Oct;42(10):737-48. Review.

PubMed [citation]
PMID:
16199547
PMCID:
PMC1735933

Fifteen novel mutations in the JAGGED1 gene of patients with Alagille syndrome.

Crosnier C, Driancourt C, Raynaud N, Hadchouel M, Meunier-Rotival M.

Hum Mutat. 2001;17(1):72-3.

PubMed [citation]
PMID:
11139247
See all PubMed Citations (7)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002242883.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This sequence change affects a donor splice site in intron 3 of the JAG1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in JAG1 are known to be pathogenic (PMID: 11180599). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with Alagille syndrome (PMID: 11139247, 11180599, 29483232, 31343788). ClinVar contains an entry for this variant (Variation ID: 213529). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Genomic Medicine Lab, University of California San Francisco, SCV004847132.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1paternalyesnot providednot providednot providednot providednot providednot providednot provided

From Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, SCV005068255.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 25, 2025